Pursuant to Regulation 24(vi) of the Buyback Regulations, Ajanta Pharma has informed that the Company issued a public advertisement dated 25th February, 2022 (the ‘Post Buyback Public Announcement’) for the Buyback of 11,20,000 Equity Shares, at a price of Rs 2,550, on a proportionate basis from the equity shareholders of the Company as on the record date 14th January 2022 through the tender offer process. The Post Buyback Public Announcement has been published on 26th February 2022 in newspapers, Business Standard (English & Hindi) in all edition and Pratahkal (Marathi) in Mumbai. The e-clippings of the said Advertisement are enclosed.
The above information is a part of company’s filings submitted to BSE.
